SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Drug Delivery

News in brief

Sanofi gets US FDA OK for talking injection device

14-Aug-2012
Last updated on 14-Aug-2012 at 13:25 GMT

Sanofi has received US FDA approval for an auto-injector that gives audio and visual cues to assist in the injection process.

The product - Auvi-Q (epinephrine injection, USP) – is used for the treatment of allergic reactions in people who are at risk for or have a history of anaphylaxis.

The idea is that under such life-threatening circumstances the device talks users or caregivers through each step of the injection process with audible and visual cues, including a five-second injection countdown and an alert light to signal when the injection is complete.

Sanofi licensed North American commercialization rights to Auvi-Q from Intelliject, which has retained commercialization rights for the rest of the world.

Bryan Downey, Vice President, Auvi-Q, Sanofi US, said: “With this FDA approval, Auvi-Q will become the first-and-only epinephrine auto-injector that talks users through each step of the injection process,”

The French drugmaker licensed North American commercialization rights to Auvi-Q from Intelliject, which has retained commercialization rights for the rest of the world.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Related products

Key Industry Events

 

Access all events listing

Our events, Events from partners...